THER-RAD.00012 Electrophysiology-Guided Noninvasive Stereotactic Cardiac Radioablation Form
Procedure is not covered
This document addresses the use of electrophysiology-guided noninvasive stereotactic cardiac radioablation, also known as stereotactic arrhythmia radiotherapy (STAR), as a treatment modality for cardiac arrhythmias, including drug and ablation refractory ventricular tachycardia (VT) and cardiomyopathy related to premature ventricular contractions (PVC).
Note: For more information on the treatment of cardiac arrythmias, please see the following:
- CG-SURG-55 Cardiac Electrophysiological Studies (EPS) and Catheter Ablation
- CG-SURG-63 Cardiac Resynchronization Therapy with or without an Implantable Cardioverter Defibrillator for the Treatment of Heart Failure
- CG-SURG-97 Cardioverter Defibrillators
Position Statement
Investigational and Not Medically Necessary:
The use of electrophysiology-guided noninvasive stereotactic cardiac radioablation is considered investigational and not medically necessary as a treatment modality for all indications, including drug and ablation refractory ventricular tachycardia and cardiomyopathy related to premature ventricular contractions.
Walk through this policy with us
Review how this policy can be converted into cited criteria, prior authorization checks, and operational automation.